Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.
<h4>Objective</h4>The objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA).<h4>Methods</h4>This was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA (SCRIPT, ST...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49652c7e07ca420993dde7e84ab236dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|